{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:25:41Z","timestamp":1789878341730,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Serbian Ministry of Education, Science and Technological Development","award":["OI175053"],"award-info":[{"award-number":["OI175053"]}]},{"name":"Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, USA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s13402-018-0392-6","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T09:21:11Z","timestamp":1530004871000},"page":"541-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["TLR4 and RAGE conversely mediate pro-inflammatory S100A8\/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms"],"prefix":"10.1007","volume":"41","author":[{"given":"Marijana","family":"Kova\u010di\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Mitrovi\u0107-Ajti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojana","family":"Beleslin-\u010coki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragoslava","family":"Djiki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijana","family":"Suboti\u010dki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"Dikli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Lekovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Goti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Mossuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0362-1449","authenticated-orcid":false,"given":"Vladan P.","family":"\u010coki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"392_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.leukres.2012.10.020","volume":"37","author":"HC Hasselbalch","year":"2013","unstructured":"H.C. Hasselbalch, Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development? Leuk Res 37, 214\u2013220 (2013)","journal-title":"Leuk Res"},{"key":"392_CR2","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00726-010-0528-0","volume":"41","author":"J Goyette","year":"2011","unstructured":"J. Goyette, C.L. Geczy, Inflammation-associated S100 proteins: New mechanisms that regulate function. Amino Acids 41, 821\u2013842 (2011)","journal-title":"Amino Acids"},{"key":"392_CR3","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1093\/carcin\/bgn188","volume":"29","author":"O Turovskaya","year":"2008","unstructured":"O. Turovskaya, D. Foell, P. Sinha, T. Vogl, R. Newlin, J. Nayak, M. Nguyen, A. Olsson, P.P. Nawroth, A. Bierhaus, N. Varki, M. Kronenberg, H.H. Freeze, G. Srikrishna, RAGE, carboxylated glycans and S100A8\/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29, 2035\u20132043 (2008)","journal-title":"Carcinogenesis"},{"key":"392_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2013.10.036","volume":"344","author":"IJ Bettum","year":"2014","unstructured":"I.J. Bettum, K. Vasiliauskaite, V. Nygaard, T. Clancy, S.J. Pettersen, E. Tenstad, G.M. Maelandsmo, L. Prasmickaite, Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties. Cancer Lett 344, 28\u201339 (2014)","journal-title":"Cancer Lett"},{"key":"392_CR5","first-page":"89","volume":"4","author":"H Chen","year":"2014","unstructured":"H. Chen, C. Xu, Q. Jin, Z. Liu, S100 protein family in human cancer. Am J Cancer Res 4, 89\u2013115 (2014)","journal-title":"Am J Cancer Res"},{"key":"392_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/cei.12139","volume":"173","author":"X Xu","year":"2013","unstructured":"X. Xu, H. Chen, X. Zhu, Y. Ma, Q. Liu, Y. Xue, H. Chu, W. Wu, J. Wang, H. Zou, S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1\/2, mitogen-activated protein-kinase and nuclear factor-\u03baB-dependent pathways. Clin Exp Immunol 173, 523\u2013535 (2013)","journal-title":"Clin Exp Immunol"},{"key":"392_CR7","doi-asserted-by":"publisher","first-page":"R69","DOI":"10.1186\/ar1939","volume":"8","author":"K Sunahori","year":"2006","unstructured":"K. Sunahori, M. Yamamura, J. Yamana, K. Takasugi, M. Kawashima, H. Yamamoto, W.J. Chazin, Y. Nakatani, S. Yui, H. Makino, The S100A8\/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther 8, R69 (2006)","journal-title":"Arthritis Res Ther"},{"key":"392_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/mc.22517","volume":"56","author":"T Suboti\u010dki","year":"2017","unstructured":"T. Suboti\u010dki, O. Mitrovi\u0107 Ajti\u0107, B.B. Beleslin-\u010coki\u0107, R. Nienhold, M. Dikli\u0107, D. Djiki\u0107, D. Lekovi\u0107, T. Bulat, D. Markovi\u0107, M. Goti\u0107, C.T. Noguchi, A.N. Schechter, R.C. Skoda, V.P. \u010coki\u0107, Angiogenic factors are increased in circulating granulocytes and CD34+ cells of myeloproliferative neoplasms. Angiogenic factors are increased in circulating granulocytes and CD34+ cells of myeloproliferative neoplasms. Mol Carcinog 56, 567\u2013579 (2017)","journal-title":"Mol Carcinog"},{"key":"392_CR9","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/rheumatology\/keu031","volume":"53","author":"LA Cerezo","year":"2014","unstructured":"L.A. Cerezo, M. Rem\u00e1kov\u00e1, M. Tom\u010dik, S. Gay, M. Neidhart, E. Lukanidin, K. Pavelka, M. Grigorian, J. Vencovsk\u00fd, L. \u0160enolt, The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis. Rheumatology 53, 1520\u20131526 (2014)","journal-title":"Rheumatology"},{"key":"392_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135463","volume":"10","author":"VP \u010coki\u0107","year":"2015","unstructured":"V.P. \u010coki\u0107, P. Mossuz, J. Han, N. Socoro, B.B. Beleslin-\u010coki\u0107, O. Mitrovi\u0107, T. Suboti\u010dki, M. Dikli\u0107, D. Lekovi\u0107, M. Goti\u0107, R.K. Puri, C.T. Noguchi, A.N. Schechter, Microarray and proteomic analyses of myeloproliferative neoplasms with a highlight on the mTOR signaling pathway. PLoS One 10, e0135463 (2015)","journal-title":"PLoS One"},{"key":"392_CR11","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1182\/blood-2014-02-554634","volume":"123","author":"R Rampal","year":"2014","unstructured":"R. Rampal, F. Al-Shahrour, O. Abdel-Wahab, J.P. Patel, J.P. Brunel, C.H. Mermel, A.J. Bass, J. Pretz, J. Ahn, T. Hricik, O. Kilpivaara, M. Wadleigh, L. Busque, D.G. Gilliland, T.R. Golub, B.L. Ebert, R.L. Levine, Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis. Blood 123, e123\u2013e133 (2014)","journal-title":"Blood"},{"key":"392_CR12","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00277-011-1179-2","volume":"90","author":"E Albizua","year":"2011","unstructured":"E. Albizua, M. Gallardo, S. Barrio, I. Rapado, A. Jimenez, R. Ayala, D. Rueda, B. Sanchez-Espiridion, E. Puigdecanet, B. Espinet, L. Florensa, C. Besses, J. Martinez-Lopez, Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia. Ann Hematol 90, 939\u2013946 (2011)","journal-title":"Ann Hematol"},{"key":"392_CR13","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1038\/sj.leu.2404338","volume":"20","author":"RA Mesa","year":"2006","unstructured":"R.A. Mesa, A. Tefferi, T.S. Lasho, D. Loegering, R.F. McClure, H.L. Powell, et al., Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myeloid metaplasia. Leukemia 20, 1800\u20131808 (2006)","journal-title":"Leukemia"},{"key":"392_CR14","volume":"2","author":"A Wolf","year":"2013","unstructured":"A. Wolf, R. Eulenfeld, K. G\u00e4bler, C. Rolvering, S. Haan, I. Behrmann, B. Denecke, C. Haan, F. Schaper, JAK2-V617F-induced MAPK activity is regulated by PI3K and acts synergistically with PI3K on the proliferation of JAK2-V617F-positive cells. JAKSTAT 2, e24574 (2013)","journal-title":"JAKSTAT"},{"key":"392_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2003.08.021","volume":"171","author":"T Hasegawa","year":"2003","unstructured":"T. Hasegawa, A. Kosaki, T. Kimura, H. Matsubara, Y. Mori, M. Okigaki, H. Masaki, N. Toyoda, M. Inoue-Shibata, Y. Kimura, M. Nishikawa, T. Iwasaka, The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages. Atherosclerosis 171, 211\u2013218 (2003)","journal-title":"Atherosclerosis"},{"key":"392_CR16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/art.24295","volume":"60","author":"RR Yammani","year":"2009","unstructured":"R.R. Yammani, D. Long, R.F. Loeser, Interleukin-7 stimulates secretion of S100A4 by activating the JAK\/STAT signaling pathway in human articular chondrocytes. Arthritis Rheum 60, 792\u2013800 (2009)","journal-title":"Arthritis Rheum"},{"key":"392_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2840-5-6","volume":"5","author":"P Ehlermann","year":"2006","unstructured":"P. Ehlermann, K. Eggers, A. Bierhaus, Most P, Weichenhan D, Greten J, Nawroth PP, Katus HA, Remppis a. Increased proinflammatory endothelial response to S100A8\/A9 after preactivation through advanced glycation end products. Cardiovasc Diabetol 5, 6 (2006)","journal-title":"Cardiovasc Diabetol"},{"key":"392_CR18","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/rheumatology\/keq380","volume":"50","author":"Z Rasheed","year":"2011","unstructured":"Z. Rasheed, N. Akhtar, T.M. Haqqi, Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-\u03baB in human osteoarthritis chondrocytes. Rheumatology 50, 838\u2013851 (2011)","journal-title":"Rheumatology"},{"key":"392_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1189\/jlb.0903435","volume":"76","author":"S Ghavami","year":"2004","unstructured":"S. Ghavami, C. Kerkhoff, M. Los, M. Hashemi, C. Sorg, F. Karami-Tehrani, Mechanism of apoptosis induced by S100A8\/A9 in colon cancer cell lines: The role of ROS and the effect of metal ions. J Leukoc Biol 76, 169\u2013175 (2004)","journal-title":"J Leukoc Biol"},{"key":"392_CR20","first-page":"248574","volume":"2012","author":"C Li","year":"2012","unstructured":"C. Li, S. Li, C. Jia, L. Yang, Z. Song, Y. Wang, Low concentration of S100A8\/9 promotes angiogenesis-related activity of vascular endothelial cells: Bridges among inflammation, angiogenesis, and tumorigenesis? Mediat Inflamm 2012, 248574 (2012)","journal-title":"Mediat Inflamm"},{"key":"392_CR21","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1182\/blood-2015-11-679431","volume":"127","author":"Y Yang","year":"2016","unstructured":"Y. Yang, H. Akada, D. Nath, R.E. Hutchison, G. Mohi, Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm. Blood 127, 3410\u20133423 (2016)","journal-title":"Blood"},{"key":"392_CR22","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.4049\/jimmunol.1601643","volume":"198","author":"DE Kennedy","year":"2017","unstructured":"D.E. Kennedy, K.L. Knight, Inflammatory changes in bone marrow microenvironment associated with declining B Lymphopoiesis. J Immunol 198, 3471\u20133479 (2017)","journal-title":"J Immunol"},{"key":"392_CR23","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.4049\/jimmunol.171.5.2602","volume":"171","author":"K Vandal","year":"2003","unstructured":"K. Vandal, P. Rouleau, A. Boivin, C. Ryckman, M. Talbot, P.A. Tessier, Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol 171, 2602\u20132609 (2003)","journal-title":"J Immunol"},{"key":"392_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/imm.12352","volume":"144","author":"JH Kang","year":"2015","unstructured":"J.H. Kang, S.M. Hwang, I.Y. Chung, S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal-regulated kinase and nuclear factor-\u03baB pathways. Immunology 144, 79\u201390 (2015)","journal-title":"Immunology"},{"key":"392_CR25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/bjh.12308","volume":"161","author":"S Barrio","year":"2013","unstructured":"S. Barrio, M. Gallardo, A. Arenas, R. Ayala, I. Rapado, D. Rueda, A. Jimenez, E. Albizua, C. Burgaleta, F. Gilsanz, J. Martinez-Lopez, Inhibition of related JAK\/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm. Br J Haematol 161, 667\u2013676 (2013)","journal-title":"Br J Haematol"},{"key":"392_CR26","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1182\/blood-2015-11-681932","volume":"127","author":"I Chachoua","year":"2016","unstructured":"I. Chachoua, C. Pecquet, M. El-Khoury, H. Nivarthi, R.I. Albu, C. Marty, V. Gryshkova, J.P. Defour, G. Vertenoeil, A. Ngo, A. Koay, H. Raslova, P.J. Courtoy, M.L. Choong, I. Plo, W. Vainchenker, R. Kralovics, S.N. Constantinescu, Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants. Blood 127, 1325\u20131335 (2016)","journal-title":"Blood"},{"key":"392_CR27","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/jcmm.12162","volume":"17","author":"N Bartalucci","year":"2013","unstructured":"N. Bartalucci, L. Tozzi, C. Bogani, S. Martinelli, G. Rotunno, J.L. Villeval, A.M. Vannucchi, Co-targeting the PI3K\/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms. J Cell Mol Med 17, 1385\u20131396 (2013)","journal-title":"J Cell Mol Med"},{"key":"392_CR28","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.12659\/MSM.908895","volume":"24","author":"C Liu","year":"2018","unstructured":"C. Liu, G. Xing, C. Wu, J. Zhu, M. Wei, D. Liu, Y. Ge, Y. Chen, T. Lei, Y. Yang, Inhibition of expression of the S100A8 gene encoding the S100 calcium-binding protein A8 promotes apoptosis by suppressing the phosphorylation of protein kinase B (Akt) in endometrial carcinoma and HEC-1A cells. Med Sci Monit 24, 1836\u20131846 (2018)","journal-title":"Med Sci Monit"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13402-018-0392-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-018-0392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-018-0392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T19:27:59Z","timestamp":1561490879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-018-0392-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["392"],"URL":"https:\/\/doi.org\/10.1007\/s13402-018-0392-6","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,26]]},"assertion":[{"value":"13 June 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}